Bluejay Diagnostics (BJDX) Competitors $1.58 +0.02 (+0.96%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. NURO, CODX, LFWD, TNON, SINT, POAI, LUCY, STRR, ICU, and STSSShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include NeuroMetrix (NURO), Co-Diagnostics (CODX), Lifeward (LFWD), Tenon Medical (TNON), Sintx Technologies (SINT), Predictive Oncology (POAI), Innovative Eyewear (LUCY), Star Equity (STRR), SeaStar Medical (ICU), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors NeuroMetrix Co-Diagnostics Lifeward Tenon Medical Sintx Technologies Predictive Oncology Innovative Eyewear Star Equity SeaStar Medical Sharps Technology NeuroMetrix (NASDAQ:NURO) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations. Do insiders & institutionals have more ownership in NURO or BJDX? 19.4% of NeuroMetrix shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 7.3% of NeuroMetrix shares are owned by insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, NURO or BJDX? NeuroMetrix has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Is NURO or BJDX more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets NeuroMetrix-203.71% -42.56% -39.26% Bluejay Diagnostics N/A -322.46%-262.96% Does the media refer more to NURO or BJDX? In the previous week, NeuroMetrix's average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score. Company Overall Sentiment NeuroMetrix Neutral Bluejay Diagnostics Neutral Which has preferable valuation and earnings, NURO or BJDX? NeuroMetrix has higher revenue and earnings than Bluejay Diagnostics. NeuroMetrix is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroMetrix$3.03M3.09-$6.53M-$4.59-0.99Bluejay Diagnostics$250K9.39-$7.72M-$379.740.00 SummaryNeuroMetrix beats Bluejay Diagnostics on 8 of the 11 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.35M$6.76B$5.56B$9.41BDividend YieldN/A1.32%4.00%4.03%P/E Ratio0.0025.7628.3619.88Price / Sales9.3995.06443.6399.98Price / CashN/A20.4724.9928.17Price / Book0.154.658.285.72Net Income-$7.72M$176.14M$3.23B$257.57M7 Day Performance-3.96%2.65%3.82%3.74%1 Month Performance0.96%4.03%9.69%14.06%1 Year Performance-94.99%6.35%34.31%17.27% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.4939 of 5 stars$1.58+1.0%N/A-95.0%$2.35M$250K0.009Positive NewsNURONeuroMetrixN/A$4.55+4.4%N/A+19.8%$9.37M$3.03M-0.9920High Trading VolumeCODXCo-Diagnostics3.7942 of 5 stars$0.27+6.1%$5.50+1,973.9%-77.7%$8.90M$3.91M-0.23100High Trading VolumeLFWDLifeward1.959 of 5 stars$0.75+2.9%$9.00+1,100.0%-80.6%$8.26M$25.66M-0.2560TNONTenon Medical1.536 of 5 stars$1.03+1.0%$4.67+353.1%+75.1%$7.82M$3.28M-0.048SINTSintx Technologies2.9638 of 5 stars$2.97-10.8%$28.00+842.8%-45.5%$7.46M$2.89M-0.0640Positive NewsGap DownHigh Trading VolumePOAIPredictive Oncology2.701 of 5 stars$0.80+1.3%$3.00+275.0%-28.0%$7.14M$1.62M-0.2630LUCYInnovative Eyewear0.1149 of 5 stars$2.15+1.4%N/A-60.5%$6.66M$1.71M-0.549News CoverageGap UpSTRRStar Equity3.5168 of 5 stars$1.96-2.0%$5.00+155.1%-55.8%$6.29M$57.17M-0.57460Positive NewsICUSeaStar Medical0.5616 of 5 stars$0.56-5.3%N/A-90.8%$6.27M$428K-0.162STSSSharps Technology0.865 of 5 stars$5.87+2.4%N/AN/A$5.98MN/A0.003 Related Companies and Tools Related Companies NeuroMetrix Alternatives Co-Diagnostics Alternatives Lifeward Alternatives Tenon Medical Alternatives Sintx Technologies Alternatives Predictive Oncology Alternatives Innovative Eyewear Alternatives Star Equity Alternatives SeaStar Medical Alternatives Sharps Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
